Megan McGill Takes the Helm as CEO of Brenig Therapeutics to Drive Innovation in Neurodegenerative Treatments Brenig Therapeutics announces the appointment of Dr. Megan McGill as CEO, focusing on advancements in therapies for neurodegenerative diseases driven by innovative discovery platforms.

Megan McGill Takes the Helm as CEO of Brenig Therapeutics to Drive Innovation in Neurodegenerative Treatments #USA #Somerville #Brenig_Therapeutics #Neurodegenerative_Diseases #Megan_McGill